Anonymous v Roche: alleged conflict of interest (rep married to hepatitis C nurse specialist) – No breach

📅 2008 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/2421/7/11 (PDF refers to CASE AUTH/2421/4/11)
CompanyRoche
ComplainantAnonymous, non-contactable NHS employee
ProductPegasys (peginterferon alfa-2a)
Main issueAlleged conflict of interest (representative married to hepatitis C CNS at hospital in territory), plus bonuses/reward trip and speaker fees
Clauses consideredClauses 2, 9.1, 15.2, 15.7 and 20.1
DecisionNo breach of the Code
Panel notesConcerns about perception/COI; 2010 incentive payment “on the limits of acceptability”; insufficient evidence on balance of probabilities
Complaint received18 July 2011
Case completed17 August 2011
AppealNo appeal
SanctionsNone

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous, non-contactable NHS employee complained about Roche’s promotion of Pegasys (peginterferon alfa-2a) for hepatitis C.
  • The complaint focused on a Roche representative whose wife worked as a hepatitis C clinical nurse specialist (CNS) at a large teaching hospital in his territory.
  • The complainant alleged the wife was responsible for choosing hepatitis C treatment and that this created a conflict of interest.
  • The complainant alleged the couple benefited from large cash bonuses, a Caribbean trip reward, and additional income via speaker fees paid to the representative’s wife for Roche meetings.
  • Roche said the representative declared the potential conflict to line management; the wife did not actively prescribe and was not able to influence patient medication; and Pegasys was already the treatment of choice at the hospital before either worked there.
  • Roche said the wife spoke at four Roche meetings since 2009 under contract, with sponsorship disclosure required on slides.
  • Roche provided details of salary/incentives (2008–2010) and documentation for the incentive scheme and “Platinum” reward trip; the wife attended the trip as the representative’s guest.
⚖️

Outcome

  • No breach of the Code was found.
  • The Panel noted the complainant was anonymous and non-contactable, with few details provided, making the allegations difficult to resolve and evidence harder to weigh.
  • The Panel had concerns about the potential conflict of interest and the impression created, and considered the 2010 incentive payment “on the limits of acceptability,” but concluded there was insufficient evidence (on the balance of probabilities) of conduct contrary to the Code.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training